PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
January 25, 2026Journal of the Formosan Medical Association1 citationsOpen Access

Delta-like 1 homologue (DLK1) predicts clinical outcomes in patients with hepatocellular carcinoma

View Full Paper
KHKuan-Fu HuangTCTian-Huei ChuCHChao‐Hung Hung

Key Points

  • This research aims to evaluate the relationship between DLK1 expression and clinical outcomes in hepatocellular carcinoma (HCC).
  • Analyzed DLK1 expression levels in HCC patients
  • Correlated DLK1 levels with clinical factors such as BCLC stages and tumor size
  • Assessed prognosis post-surgical resection.
  • Elevated DLK1 expression is associated with advanced BCLC stages in HCC
  • Higher DLK1 levels correlate with larger tumor sizes
  • Patients with increased DLK1 expression exhibit poorer prognosis after resection.

Abstract

Our findings suggest that elevated DLK1 expression in HCC is linked to advanced BCLC stages, big tumor sizes and poor prognosis in HCC patients after surgical resection. DLK1 seems to serve as a valuable biomarker and may be a candidate for therapeutic targeting of HCC pending further validation.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Huang et al. (2026) studied this question.

synapsesocial.com/papers/6975b1a9feba4585c2d6d200https://doi.org/10.1016/j.jfma.2026.01.022
Ask AI
Helpful
Bookmark
Share
View Full Paper